SCHEMBL18714101

SCHEMBL18714101

Cc1c(-c2ccc3nc[nH]c3c2)cc(Nc2ccc(N3CCOCC3)cn2)c2nccn12

nearest known ligand 0.80

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ SYK P43405 20/20 0.80

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6911219 0.89 SYK (1.00) SYK
SCHEMBL2423668 0.85 SYK (1.00) SYK
SCHEMBL18454407 0.83 SYK (0.67) SYK
SCHEMBL2473280 0.83 SYK (0.57) SYK
SCHEMBL6911190 0.81 SYK (0.78) SYK
SCHEMBL2425074 0.79 SYK (0.65) SYK
SCHEMBL2427923 0.78 SYK (0.63) SYK
SCHEMBL16223559 0.77 SYK (0.62) SYK
SCHEMBL2403533 0.77 SYK (1.00) SYK
SCHEMBL15168382 0.76 SYK (0.62) SYK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170095490-A1 IMIDAZOPYRIDINES SYK INHIBITORS Kronos Bio, Inc. 2017-04-06 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170095490-A1 IMIDAZOPYRIDINES SYK INHIBITORS SYK, BTK, ZAP70 SYK 1/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback